Denny's
DENN:US US24869P1049
Key Information
HQ:
United States
Market Cap:
$0.98bn
Primary Markets:
North America, LATAM
Antibiotics Stewardship Engagement
Analysis Overview
Scope of Policy Policy Implementation Investor Engagement
Analysis Breakdown
Scope of Policy
9/16
Does the company have a policy on antibiotics stewardship?
Yes, Denny's policy is publicly available on its website as part of its broader Animal Welfare Policy.
4/4
Does it cover animal-derived protein sources across all relevant species?
The company's policy covers chicken only, despite sourcing other species.
1/4
Does it cover animal-derived protein sources across all operations?
Denny's policy is specific to the US, despite operating internationally and making brand-wide purchasing decision in collaboration with their franchises.
1/4
How strong is the company's commitment?
The company has strengthened its policy on antibiotics by committing to eliminating the use of medically important antibiotics in all chicken served at Denny's U.S. locations effective with purchases beginning 1 March 2019.
3/4
Policy Implementation
2/18
Does the policy commit to specific targets or timelines for all species?
The company has stated its policy on chicken will become effective with purchases beginning 1 March 2019.
2/5
Does the company disclose quantity of antibiotics used?
No information provided and/ or available.
0/7
Does the company commit to and/ or carries out third-party auditing and monitoring?
No information provided and/ or available.
0/6
Investor Engagement
2/4
Did the company respond to investor letter?
Denny's responded providing some insights, but incomplete answers to the investor questions. Denny's has not met with FAIRR. Their response is available here.
2/4
Members-only Content
To register as a member of the FAIRR network, please fill out the sign up form or if you need additional information on the FAIRR network, please contact investoroutreach@fairr.org.
Workstream Information
2019 Score:
13/38
Last Updated:
20 May 2019
2019 Resources
Phase 3 | Progress Report Antibiotics Stewardship Engagement